speb/financial-data huggingface dataset:
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 51325000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 51325000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 2235462000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2235462000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 154861000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 154861000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Minority Interests: 13766000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -5099000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Net Debt: 835117000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 835117000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Net Income: 201090000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income: 29728000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 201090000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 29728000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 187324000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 34827000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 201090000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 29728000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 201090000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 29728000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 261899000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 187324000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 34827000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Net Interest Income: -87125000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -20342000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 0.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -137433000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -174458000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -87125000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -20342000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -787000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Net PPE: 2360733000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 2360733000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -149820000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 37025000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 1965088000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1965088000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 107376000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 107376000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 51325000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 51325000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 32565000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 32565000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 498991000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 97611000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Normalized Income: 201090000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 29728000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 340549000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Operating Income: 300423000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Operating Income: 36233000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Operating Revenue: 3447235000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 891124000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 3023287.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 3023287.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 126532000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 126532000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 77651000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 77651000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 1935370000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1935370000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 515000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 515000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 4658000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 4658000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 41666000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 38773000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 38773000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -1000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -1000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 48601000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 23394000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 235365000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 95740000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Payable: 141408000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 141408000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Properties: 36882000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 36882000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 4599000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 4599000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 10052000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 10052000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Other Special Charges: -311000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Payables: 674221000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Payables: 674221000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 5310000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 16205000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 16205000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 34749000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 34749000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Pretax Income: 261899000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 39285000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 50599000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -153486000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 269978000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 269978000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 2166102000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 556471000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 149967000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 37984000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 595000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 595000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -178000000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 10052000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 10052000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 1131559000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1131559000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 0.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 3666000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 25940000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 58517000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Share Issued: 3023287.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 3023287.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 37025000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Special Income Charges: 311000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 1965603000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1965603000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 1965088000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1965088000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Tax Provision: 74575000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 4458000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.28
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.11
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 89458000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 89458000.00
HALEOSLABS.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -85000000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Total Assets: 3899911000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 3899911000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 2148282000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2148282000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Total Debt: 864085000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 864085000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 2120464000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2120464000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Total Expenses: 3146812000.00
HALEOSLABS.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 854891000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1779447000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1779447000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 2394174000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2394174000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 358772000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 358772000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 3123000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 0.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 311000.00
HALEOSLABS.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 311000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Work In Process: 176200000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 176200000.00
HALEOSLABS.NS balance_sheet (annual, 2025-03-31) — Working Capital: 85062000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 85062000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 229706000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 825046000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3023200.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 13.75
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 516441000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 38238000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 38238000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3023200.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 13.75
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 41569000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — EBIT: 88858000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — EBITDA: 127096000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 308605000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 18652000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 18652000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -2252000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income: 41569000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 41569000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 43821000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 41569000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 41569000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 43821000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -18652000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -18652000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 127096000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 41569000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Operating Income: 78899000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 825046000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 9959000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 28551000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 70206000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 516441000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 38238000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 26385000.00
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.38
HALEOSLABS.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 746147000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 233443000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 813676000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 535081000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 610442000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 33238000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 3022585.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 20.19
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 20573000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 30233000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 5392000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 15710000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 30233000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2064182000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 90129000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 483396000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 1486824000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 7973000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 549951000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 557924000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1407282000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 17348000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 38863000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 38863000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 3022585.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 20.19
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 61026000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — EBIT: 101078000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — EBITDA: 139941000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 398000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2348107000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 330280000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 16153000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 16153000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 710432000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2741474000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 33238000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 12600000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 127341000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 139941000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 54682000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 160573000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -3227000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 671900000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Net Income: 61026000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 61026000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 64253000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 61026000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 61026000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 64253000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -16153000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -16153000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 2348107000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2063784000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 112207000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 139941000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 61026000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Operating Income: 96837000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 813676000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 3023287.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 150240000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 160748000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 2033949000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 70300000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 4241000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 32296000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 2257978000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 10318000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Payables: 553078000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 84925000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 483396000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 38863000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 3023287.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2064182000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2063784000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 20672000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 0.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 3938867000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2191523000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 697865000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2224755000.00
HALEOSLABS.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 716839000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1714112000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2452043000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 306830000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 17997000.00
HALEOSLABS.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 79542000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 235039000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 947831000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 3022750.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 21.89
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 611406000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 39099000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 39099000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 3022750.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 21.89
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 66168000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — EBIT: 103220000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 142319000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 336425000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 15443000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 15443000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -321000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income: 66168000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 66168000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 66489000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 66168000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 66168000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 66489000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -15443000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -15443000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 142319000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 66168000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Operating Income: 101386000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 947831000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1834000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 28975000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 87777000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 611406000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 39099000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 21288000.00
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.24
HALEOSLABS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 846445000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 996508000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 288657000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 3337945000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 751391000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 614061000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 614061000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 613393000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 613393000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 34423000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 34423000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 3023402.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 3025694.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Basic EPS: 57.26
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 1.44
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 5029000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -578621000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 16855000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 16855000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 30233000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 30233000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 12084000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 12084000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 23693000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 23693000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -4535000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -124264000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -502849000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 469629000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Change In Payable: 91482000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Change In Prepaid Assets: -3932000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 78441000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 8507000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 7055000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 30233000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 30233000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 2135478000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2135478000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 104221000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 104221000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 2049355000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 459624000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 1631055000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1631055000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 8759000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 8759000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Current Debt: 588946000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 588946000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 597705000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 597705000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1562775000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1562775000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 18889000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 18889000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Depreciation: 154689000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 154689000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 154688000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 38489000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 154688000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 38489000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 3023402.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 3025694.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Diluted EPS: 57.26
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.44
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 173120000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 4357000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — EBIT: 316416000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — EBIT: 23259000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — EBITDA: 471105000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 61748000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 12084000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 213784000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -206386000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 12000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 282000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 282000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 2781130000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2781130000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Gross Profit: 1288590000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 291767000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Interest Expense: 64452000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 14204000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 64452000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 14204000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -23316000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 725000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Inventory: 798242000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 798242000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 3224003000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3224003000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -578964000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 34423000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 34423000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 401602000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 8096000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 8096000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 499579000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 499579000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 507675000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 507675000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 459180000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -152883000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 49336000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 49336000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 160083000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 160083000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Minority Interests: -4883000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 917000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1076441000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1076441000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Net Income: 173120000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income: 4357000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 173120000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 4357000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 178003000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3439000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 173120000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 4357000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 173120000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 4357000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 251964000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 178003000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3439000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Net Interest Income: -64452000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -14204000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 248719000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 306297000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -64452000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -14204000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -1520000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Net PPE: 2781130000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 2781130000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -578169000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -57578000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 2135196000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2135196000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 128737000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 128737000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 471105000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 61748000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Normalized Income: 173120000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 4357000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 372235000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Operating Income: 292082000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Operating Income: 3110000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Operating Revenue: 3337945000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 751391000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 3023287.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 3023287.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 177738000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 177738000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 161382000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 161382000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 2105245000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 2105245000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 23085000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 97194000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 97194000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 24334000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 20149000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 187995000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 88509000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Other Properties: 2676909000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 2676909000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 11609000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 11609000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Payables: 614061000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Payables: 614061000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 2941000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Pretax Income: 251964000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 9055000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -3963000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -578621000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 2049355000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 459624000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 154689000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 38489000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -152883000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 452000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Share Issued: 3023287.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 3023287.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: -57578000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 2135478000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2135478000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 2135196000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2135196000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Tax Provision: 73961000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 5616000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.29
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 17989000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 17989000.00
HALEOSLABS.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -65000000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Total Assets: 4544084000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 4544084000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 2635057000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2635057000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Total Debt: 1105380000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1105380000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 2295561000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2295561000.00
HALEOSLABS.NS income_statement (annual, 2026-03-31) — Total Expenses: 3045863000.00
HALEOSLABS.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 748281000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 2248523000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2248523000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 2913029000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2913029000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 685748000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 685748000.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
HALEOSLABS.NS balance_sheet (annual, 2026-03-31) — Working Capital: 68280000.00
HALEOSLABS.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 68280000.00
HALO balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -1140000.00
HALO balance_sheet (annual, 2021-12-31) — Current Debt: 89419000.00
HALO balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 89419000.00
HALO balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 1746000.00